Clinical Trials Browser

Phase 2 × Carcinoma, Non-Small-Cell Lung × Biopsy, Needle × Clear all

NCT00673569 2010-08-09

Laboratory Test in Predicting Response to Erlotinib in Patients With Relapsed Metastatic or Unresectable Non-Small Cell Lung Cancer That Did Not Respond to Previous Treatment

Phase 2 Completed

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms